Therefore, reduced expression of VDAC1, such as that in VDAC1+/− mice, may be beneficial for synaptic activity and may protect against the toxicity of AD-related genes, eventually leading to normal function of the mitochondria that supply ATP to nerve terminals and to the enhancement of synaptic and cognitive function in AD. Here, VDAC1 is linked to Alzheimer disease.